Voyager Therapeutics (VYGR) Construction in Progress (2016)
Voyager Therapeutics (VYGR) posted Construction in Progress of $3.0 million for Q4 2016.
Voyager Therapeutics (VYGR) Construction in Progress (2016) Analysis & Trends
Voyager Therapeutics has reported Construction in Progress for 1 years, with the latest figure at $3.0 million in Q4 2016.
- Quarterly Construction in Progress changed N/A year-over-year to $3.0 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $3.0 million (changed N/A YoY) and the FY2016 annual result came in at $3.0 million, changed N/A from the prior year.
- Construction in Progress steadied at $3.0 million in Q4 2016 per VYGR's latest filing.
- Over five years, Construction in Progress peaked at $3.0 million in Q4 2016 and troughed at $3.0 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 152.67 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Voyager Therapeutics | 201.32 Mn | 84.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 3.00 Mn |